Search Results

Risk of additional cancers in untreated and treated hairy cell leukemia patients

Authors: Dasanu, Constantin A; Alexandrescu, Doru T

Source: Expert Opinion on Pharmacotherapy, Volume 11, Number 1, January 2010 , pp. 41-50(10)

Publisher: Informa Healthcare

Inherent and iatrogenic immune defects in hairy cell leukemia: revisited

Authors: Dasanu, Constantin A; Ichim, TE; Alexandrescu, Doru T

Source: Expert Opinion on Drug Safety, Volume 9, Number 1, January 2010 , pp. 55-64(10)

Publisher: Informa Healthcare

Immunophenotyping of mature B-cell non Hodgkin lymphoma involving bone marrow and peripheral blood: critical analysis and insights gained at a tertiary care cancer hospital

Authors: Gujral, Sumeet; Polampalli, Sunita Narayan; Badrinath, Y.; Kumar, Ashok; P. G., Subramanian; Nair, Reena; Gupta, Sudeep; Sengar, Manju; Nair, Chandralekha

Source: Leukemia and Lymphoma, Volume 50, Number 8, August 2009 , pp. 1290-1300(11)

Publisher: Informa Healthcare

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Author: Kreitman, Robert J.

Source: Current Pharmaceutical Design, Volume 15, Number 23, August 2009 , pp. 2652-2664(13)

Publisher: Bentham Science Publishers

Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients

Authors: Damaj, Ghandi; Kuhnowski, Frédérique; Marolleau, Jean-Pierre; Bauters, Francis; Leleu, Xavier; Yakoub-Agha, Ibrahim

Source: European Journal of Haematology, Volume 83, Number 3, September 2009 , pp. 246-250(5)

Publisher: Blackwell Publishing

Cladribine: not just another purine analogue?

Authors: Spurgeon, Stephen; Yu, Margaret; Phillips, John D; Epner, Elliot M

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1169-1181(13)

Publisher: Informa Healthcare

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Author: Robak, Tadeusz

Source: Current Medicinal Chemistry, Volume 16, Number 18, June 2009 , pp. 2212-2234(23)

Publisher: Bentham Science Publishers

Has Success Spoiled Hairy Cell Leukemia Research? Key Questions Go Unanswered, Despite Big Gains

Author: Holzman, David

Source: Journal of the National Cancer Institute, Volume 101, Number 6, 18 March 2009 , pp. 370-373(4)

Publisher: Oxford University Press

Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies

Author: Kreitman, Robert J.

Source: BioDrugs, Volume 23, Number 1, 2009 , pp. 1-13(13)

Publisher: Adis International

Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia - a multicentre trial SAKK 32/95

Authors: Zenhausern, Reinhard; Von Rohr, Albert; Rufibach, Kaspar; Solenthaler, Max; Meyer-Monard, Sandrine; Gratwohl, Alois; Hess, Urs; Bargetzi, Mario; Kovacsovic, Tibor; Leoncini, Leda; Tobler, Andreas

Source: Leukemia and Lymphoma, Volume 50, Number 1, January 2009 , pp. 133-136(4)

Publisher: Informa Healthcare

Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia

Authors: Benz, Rudolf; Siciliano, Raffaele Daniele; Stussi, Georg; Fehr, Jörg

Source: European Journal of Haematology, Volume 82, Number 3, March 2009 , pp. 194-200(7)

Publisher: Blackwell Publishing

Protein-tyrosine phosphatase activity maintains the viability of hairy cells and modulates their response to interferon-α

Authors: Allsup, David; Harris, Robert; Baker, Peter; Cawley, John

Source: Leukemia and Lymphoma, Volume 49, Number 12, December 2008 , pp. 2351-2358(8)

Publisher: Informa Healthcare

Hairy Cell Leukemia: Current Concepts

Authors: Cannon, Timothy; Mobarek, Dalia; Wegge, Julia; Tabbara, Imad

Source: Cancer Investigation, Volume 26, Number 8, October 2008 , pp. 860-865(6)

Publisher: Informa Healthcare

Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab

Authors: Angelopoulou, Maria; Pangalis, Gerassimos; Sachanas, Sotirios; Kokoris, Styliani; Anargyrou, Konstantinos; Galani, Zaharoula; Kalpadakis, Christina; Vassilakopoulos, Theodoros

Source: Leukemia and Lymphoma, Volume 49, Number 9, September 2008 , pp. 1817-1820(4)

Publisher: Informa Healthcare

Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly

Authors: Viens, Daniel; St-Hilaire, Eve; Beauregard, Patrice; Dufresne, Jean; Knecht, Hans

Source: Leukemia and Lymphoma, Volume 49, Number 7, July 2008 , pp. 1424-1426(3)

Publisher: Informa Healthcare

Lymphome der Milz

Authors: Marx, A.; Müller-Hermelink, H.K.; Hartmann, M.; Geißinger, E.; Zettl, A.; Adam, P.; Rüdiger, T.

Source: Der Pathologe, Volume 29, Number 2, March 2008 , pp. 136-142(7)

Publisher: Springer

Cladribine in indolent non-Hodgkin's lymphoma

Authors: Sigal, Darren S; Saven, Alan

Source: Expert Review of Anticancer Therapy, Volume 8, Number 4, April 2008 , pp. 535-545(11)

Publisher: Expert Reviews

Emerging drugs for rarer chronic lymphoid leukemias

Author: Robak, Tadeusz

Source: Expert Opinion on Emerging Drugs, Volume 13, Number 1, March 2008 , pp. 95-118(24)

Publisher: Informa Healthcare

Hairy cell leukemia

Authors: Swords, Ronan; Giles, Francis

Source: Medical Oncology, Volume 24, Number 1, January 2007 , pp. 7-15(9)

Publisher: Humana Press

Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas

Authors: Karauzum, Sibel Berker; Yasar, Duygu; Dirice, Ercument; Imir, Nilufer; Luleci, Guven; Ozes, Osman Nidai

Source: Growth Factors, Volume 25, Number 2, April 2007 , pp. 94-100(7)

Publisher: Informa Healthcare